Keyphrases
Acute Gastroenteritis
6%
Age Groups
7%
Antibody Level
10%
Arab
7%
Arab children
6%
BNT162b2 Vaccine
6%
Confidence Interval
16%
Conjugate Vaccine
6%
COVID-19
12%
Diarrhea
10%
Diarrheal Disease
7%
Enterotoxigenic Escherichia Coli
9%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Epidemiology
10%
Helicobacter Pylori (H. pylori)
16%
Helicobacter Pylori Infection
15%
Hospitalization
12%
IgG Antibody
13%
Immune Response
6%
Immunization
8%
Immunogenicity
11%
Immunoglobulin
7%
Israel
100%
Israeli
21%
Israeli Arabs
10%
Israeli Population
11%
Lipopolysaccharide
20%
Non-typhoidal Salmonella
6%
Odds Ratio
5%
Older Adults
20%
Revaccination
7%
Risk Factors
14%
Rotavirus
9%
Rotavirus Gastroenteritis
7%
Rotavirus Vaccine
7%
Seroepidemiology
15%
Seropositivity
11%
Seroprevalence
18%
Shigella
35%
Shigella Flexneri
14%
Shigella Flexneri 2a
11%
Shigella Sonnei
29%
Shigella Vaccine
7%
Shigellosis
28%
Soldiers
9%
Stool
5%
Vaccination
17%
Vaccine Candidate
5%
Vaccinees
9%
Young children
7%
Immunology and Microbiology
Antibody Response
5%
Antimicrobial Resistance
5%
COVID-19
7%
ELISA
11%
Enterotoxigenic Escherichia Coli
7%
Gastroenteritis
8%
Helicobacter Pylori
19%
Hepatitis A Virus
5%
Immune Response
5%
Immunoglobulin A
10%
Immunoglobulin G
11%
Immunoglobulin G Antibody
8%
Immunoglobulin M
6%
Infectious Agent
10%
Peptoclostridium difficile
5%
Prevalence
21%
Rotavirus
5%
Salmonella
9%
Seropositivity
13%
Seroprevalence
19%
Serotype
7%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Shigella
22%
Shigella flexneri
6%
Shigella sonnei
13%
Vibrio vulnificus
5%
Virus
5%